Accent Microcell Ltd.

•

₹ 605.051.13%

2026-08-21

accentmicrocell.comBSE: -NSE: ACCENTMIC

Market Cap₹ 1,436 Cr.

Current Price₹ 598

High / Low₹ 608 / 238

Stock P/E0.0

Book Value₹ 115

Price to Book3.09

Dividend Yield0.17 %

ROCE24.9 %

ROE18.7 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2026 • Dahej (SEZ Unit): 59.4% • Pirana: 40.2% • Unit III: 0.4%

PROS

Company has delivered good profit growth of 55.6% CAGR over last 5 years
Company is almost debt free
Company has a healthy return on capital (ROCE) of 26.2%
Company has a good return on equity (ROE) track record: 3 Years ROE 21.8%
Company has delivered good sales growth of 21.4% CAGR over last 5 years
Operating margins have improved to 16.2% from 10.9%

CONS

Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.51x)
Equity base is being diluted - shares outstanding up 85.3%
Though reporting repeated profits, the company pays out little dividend (5.5%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name	CMP Rs.	P/E	Mar Cap Rs.Cr.	Div Yld %	NP Qtr Rs.Cr.	Qtr Profit Var %	Sales Qtr Rs.Cr.	Qtr Sales Var %	ROCE %	OPM %
1.	SUNPHARMA	1898.00	37.65	455393.78	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	8525.00	77.37	226311.96	0.35	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	5013.00	87.43	190678.41	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1416.00	33.94	114392.01	0.92	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1105.00	24.42	110224.17	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LUPIN	2220.00	18.36	101506.15	0.81	1416.98	16.01	8276.89	34.28	28.86	29.59
7.	MANKIND	2391.00	48.34	98747.34	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
8.	DRREDDY	1171.00	30.33	97740.54	0.68	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	LAURUSLABS	1807.00	89.30	97634.42	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
10.	AUROPHARMA	1615.15	25.03	92932.16	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	BIOCON	414.30	136.32	67518.23	0.12	136.80	53.36	4336.00	10.89	3.26	19.54
12.	ACCENTMIC	598.60	0.00	1435.98	0.17	—	—	—	—	24.88	—

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

No standalone quarterly results found

We don't have this information yet. Please check back later.

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	133	166	197	245	265	349
	122	153	178	206	223	292
Operating Profit	13	15	21	43	48	63
OPM %	10	9	11	18	18	18
Other Income	2	2	2	4	6	7
Interest	3	3	3	1	0	1
Depreciation	4	4	4	4	4	5
	6	8	15	37	44	58
Tax %	20	22	17	17	24	25
Net Profit	5	6	12	30	33	44
EPS	4	5	9	14	16	18
Dividend Payout %	9	18	8	7	6	5
Minority Interest	0	0	0	0	0	0
Share of Associates	0	0	0	0	0	0
Adjusted EPS	4	2	9	14	16	18
Minority Interest	0	0	0	0	0	0
Share of Associates	0	0	0	0	0	0
Adjusted EPS	4	2	9	14	16	18

Mar 2021

: 133
: 122
Operating Profit: 13
OPM %: 10
Other Income: 2
Interest: 3
Depreciation: 4
: 6
Tax %: 20
Net Profit: 5
EPS: 4
Dividend Payout %: 9
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 4
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 4

Mar 2022

: 166
: 153
Operating Profit: 15
OPM %: 9
Other Income: 2
Interest: 3
Depreciation: 4
: 8
Tax %: 22
Net Profit: 6
EPS: 5
Dividend Payout %: 18
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 2
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 2

Mar 2023

: 197
: 178
Operating Profit: 21
OPM %: 11
Other Income: 2
Interest: 3
Depreciation: 4
: 15
Tax %: 17
Net Profit: 12
EPS: 9
Dividend Payout %: 8
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 9
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 9

Mar 2024

: 245
: 206
Operating Profit: 43
OPM %: 18
Other Income: 4
Interest: 1
Depreciation: 4
: 37
Tax %: 17
Net Profit: 30
EPS: 14
Dividend Payout %: 7
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 14
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 14

Mar 2025

: 265
: 223
Operating Profit: 48
OPM %: 18
Other Income: 6
Interest: 0
Depreciation: 4
: 44
Tax %: 24
Net Profit: 33
EPS: 16
Dividend Payout %: 6
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 16
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 16

Mar 2026

: 349
: 292
Operating Profit: 63
OPM %: 18
Other Income: 7
Interest: 1
Depreciation: 5
: 58
Tax %: 25
Net Profit: 44
EPS: 18
Dividend Payout %: 5
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 18
Minority Interest: 0
Share of Associates: 0
Adjusted EPS: 18

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: 21%
3 Years:: 21%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 56%
3 Years:: 53%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 103%

RETURN ON EQUITY

10 Years:: —
5 Years:: 23%
3 Years:: 22%
Last Year:: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
LIABILITIES	-	-	-	-	-	-
Equity Capital	4	13	13	21	21	24
	22	19	37	143	174	251
	13	17	17	10	0	0
Trade Payables	18	30	35	19	18	20
	23	15	11	20	37	39
Total Liabilities	81	95	113	213	250	334
ASSETS	-	-	-	-	-	-
	30	30	31	29	48	53
Capital Work in Progress	0	0	0	2	13	102
	32	40	42	33	34	32
	0	0	0	54	65	91
Cash & Bank	1	3	2	72	51	20
	17	22	38	23	40	36
Total Assets	81	95	113	213	250	334
Total Debt	31	24	23	13	2	1
Net Working Capital	15	10	24	126	124	111
Contingent Liabilities	0	0	0	4	5	20
Book Value per Share	61.92	24.87	38.92	77.86	92.57	114.84
Face Value	10.00	10.00	10.00	10.00	10.00	10.00
Total Debt	31	24	23	13	2	1
Net Working Capital	15	10	24	126	124	111
Contingent Liabilities	0	0	0	4	5	20
Book Value per Share	61.92	24.87	38.92	77.86	92.57	114.84
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Mar 2021

Equity Capital: 4
: 22
: 13
Trade Payables: 18
: 23
Total Liabilities: 81
: 30
Capital Work in Progress: 0
: 32
: 0
Cash & Bank: 1
: 17
Total Assets: 81
Total Debt: 31
Net Working Capital: 15
Contingent Liabilities: 0
Book Value per Share: 61.92
Face Value: 10.00
Total Debt: 31
Net Working Capital: 15
Contingent Liabilities: 0
Book Value per Share: 61.92
Face Value: 10.00

Mar 2022

Equity Capital: 13
: 19
: 17
Trade Payables: 30
: 15
Total Liabilities: 95
: 30
Capital Work in Progress: 0
: 40
: 0
Cash & Bank: 3
: 22
Total Assets: 95
Total Debt: 24
Net Working Capital: 10
Contingent Liabilities: 0
Book Value per Share: 24.87
Face Value: 10.00
Total Debt: 24
Net Working Capital: 10
Contingent Liabilities: 0
Book Value per Share: 24.87
Face Value: 10.00

Mar 2023

Equity Capital: 13
: 37
: 17
Trade Payables: 35
: 11
Total Liabilities: 113
: 31
Capital Work in Progress: 0
: 42
: 0
Cash & Bank: 2
: 38
Total Assets: 113
Total Debt: 23
Net Working Capital: 24
Contingent Liabilities: 0
Book Value per Share: 38.92
Face Value: 10.00
Total Debt: 23
Net Working Capital: 24
Contingent Liabilities: 0
Book Value per Share: 38.92
Face Value: 10.00

Mar 2024

Equity Capital: 21
: 143
: 10
Trade Payables: 19
: 20
Total Liabilities: 213
: 29
Capital Work in Progress: 2
: 33
: 54
Cash & Bank: 72
: 23
Total Assets: 213
Total Debt: 13
Net Working Capital: 126
Contingent Liabilities: 4
Book Value per Share: 77.86
Face Value: 10.00
Total Debt: 13
Net Working Capital: 126
Contingent Liabilities: 4
Book Value per Share: 77.86
Face Value: 10.00

Mar 2025

Equity Capital: 21
: 174
: 0
Trade Payables: 18
: 37
Total Liabilities: 250
: 48
Capital Work in Progress: 13
: 34
: 65
Cash & Bank: 51
: 40
Total Assets: 250
Total Debt: 2
Net Working Capital: 124
Contingent Liabilities: 5
Book Value per Share: 92.57
Face Value: 10.00
Total Debt: 2
Net Working Capital: 124
Contingent Liabilities: 5
Book Value per Share: 92.57
Face Value: 10.00

Mar 2026

Equity Capital: 24
: 251
: 0
Trade Payables: 20
: 39
Total Liabilities: 334
: 53
Capital Work in Progress: 102
: 32
: 91
Cash & Bank: 20
: 36
Total Assets: 334
Total Debt: 1
Net Working Capital: 111
Contingent Liabilities: 20
Book Value per Share: 114.84
Face Value: 10.00
Total Debt: 1
Net Working Capital: 111
Contingent Liabilities: 20
Book Value per Share: 114.84
Face Value: 10.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	5	15	8	11	25	19
Cash from Investing	-6	-4	-4	-82	-9	-49
Cash from Financing	-2	-10	-4	72	-14	36
	-3	1	-1	1	2	6
Free Cash Flow	5	11	3	7	-9	-75
OCF / Net Profit	1.05	2.52	0.62	0.38	0.75	0.43
Cumulative 5-Year FCF	0	0	0	0	0	-64
OCF / Net Profit	1.05	2.52	0.62	0.38	0.75	0.43
Cumulative 5-Year FCF	0	0	0	0	0	-64

Mar 2021

: 5
Cash from Investing: -6
Cash from Financing: -2
: -3
Free Cash Flow: 5
OCF / Net Profit: 1.05
Cumulative 5-Year FCF: 0
OCF / Net Profit: 1.05
Cumulative 5-Year FCF: 0

Mar 2022

: 15
Cash from Investing: -4
Cash from Financing: -10
: 1
Free Cash Flow: 11
OCF / Net Profit: 2.52
Cumulative 5-Year FCF: 0
OCF / Net Profit: 2.52
Cumulative 5-Year FCF: 0

Mar 2023

: 8
Cash from Investing: -4
Cash from Financing: -4
: -1
Free Cash Flow: 3
OCF / Net Profit: 0.62
Cumulative 5-Year FCF: 0
OCF / Net Profit: 0.62
Cumulative 5-Year FCF: 0

Mar 2024

: 11
Cash from Investing: -82
Cash from Financing: 72
: 1
Free Cash Flow: 7
OCF / Net Profit: 0.38
Cumulative 5-Year FCF: 0
OCF / Net Profit: 0.38
Cumulative 5-Year FCF: 0

Mar 2025

: 25
Cash from Investing: -9
Cash from Financing: -14
: 2
Free Cash Flow: -9
OCF / Net Profit: 0.75
Cumulative 5-Year FCF: 0
OCF / Net Profit: 0.75
Cumulative 5-Year FCF: 0

Mar 2026

: 19
Cash from Investing: -49
Cash from Financing: 36
: 6
Free Cash Flow: -75
OCF / Net Profit: 0.43
Cumulative 5-Year FCF: -64
OCF / Net Profit: 0.43
Cumulative 5-Year FCF: -64

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE	-	-	-	-	-	-
EPS (₹)	11.17	4.57	9.45	14.34	15.71	18.28
Book Value (₹)	61.92	24.87	38.92	77.86	92.57	114.84
Dividend per Share (₹)	1.00	0.80	0.80	1.00	1.00	1.00
Cash EPS (₹)	6.48	2.59	12.62	16.44	17.71	20.22
PROFITABILITY	-	-	-	-	-	-
Operating Margin %	9.76%	8.93%	10.87%	16.08%	15.84%	16.24%
Net Margin %	3.62%	3.56%	6.20%	12.29%	12.50%	12.57%
ROE %	18.04%	20.07%	29.67%	28.17%	18.44%	18.65%
ROCE %	16.38%	18.78%	26.79%	30.16%	23.65%	24.88%
	5.95%	6.72%	11.77%	18.47%	14.27%	15.01%
EFFICIENCY	-	-	-	-	-	-
Debtor Days	35	33	44	63	82	82
Inventory Days	87	78	75	56	46	35
Payable Days	74	78	99	67	43	32
	47	33	20	51	85	84
FINANCIAL HEALTH	-	-	-	-	-	-
Debt to Equity (x)	1.15x	0.75x	0.45x	0.08x	0.01x	0.00x
Interest Coverage (x)	2.78x	3.48x	6.84x	32.88x	127.65x	108.87x
	1.43x	1.19x	1.43x	3.70x	3.38x	2.98x
GROWTH	-	-	-	-	-	-
Revenue Growth %	0.00%	25.00%	19.05%	24.45%	7.77%	31.92%
Operating Profit Growth %	0.00%	14.42%	44.85%	101.03%	12.10%	31.34%
Net Profit Growth %	0.00%	22.70%	107.57%	146.63%	9.60%	32.65%
	0.00%	0.00%	0.00%	51.70%	9.60%	16.36%
VALUATION	-	-	-	-	-	-
P/E (x)	0.00x	0.00x	0.00x	16.21x	11.49x	19.43x
P/B (x)	0.00x	0.00x	0.00x	2.99x	1.95x	3.09x
Dividend Yield %	0.00%	0.00%	0.00%	0.41%	0.52%	0.28%
	0.00x	0.00x	0.00x	10.61x	7.29x	13.13x

Mar 2021

EPS (₹): 11.17
Book Value (₹): 61.92
Dividend per Share (₹): 1.00
Cash EPS (₹): 6.48
Operating Margin %: 9.76%
Net Margin %: 3.62%
ROE %: 18.04%
ROCE %: 16.38%
: 5.95%
Debtor Days: 35
Inventory Days: 87
Payable Days: 74
: 47
Debt to Equity (x): 1.15x
Interest Coverage (x): 2.78x
: 1.43x
Revenue Growth %: 0.00%
Operating Profit Growth %: 0.00%
Net Profit Growth %: 0.00%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2022

EPS (₹): 4.57
Book Value (₹): 24.87
Dividend per Share (₹): 0.80
Cash EPS (₹): 2.59
Operating Margin %: 8.93%
Net Margin %: 3.56%
ROE %: 20.07%
ROCE %: 18.78%
: 6.72%
Debtor Days: 33
Inventory Days: 78
Payable Days: 78
: 33
Debt to Equity (x): 0.75x
Interest Coverage (x): 3.48x
: 1.19x
Revenue Growth %: 25.00%
Operating Profit Growth %: 14.42%
Net Profit Growth %: 22.70%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2023

EPS (₹): 9.45
Book Value (₹): 38.92
Dividend per Share (₹): 0.80
Cash EPS (₹): 12.62
Operating Margin %: 10.87%
Net Margin %: 6.20%
ROE %: 29.67%
ROCE %: 26.79%
: 11.77%
Debtor Days: 44
Inventory Days: 75
Payable Days: 99
: 20
Debt to Equity (x): 0.45x
Interest Coverage (x): 6.84x
: 1.43x
Revenue Growth %: 19.05%
Operating Profit Growth %: 44.85%
Net Profit Growth %: 107.57%
: 0.00%
P/E (x): 0.00x
P/B (x): 0.00x
Dividend Yield %: 0.00%
: 0.00x

Mar 2024

EPS (₹): 14.34
Book Value (₹): 77.86
Dividend per Share (₹): 1.00
Cash EPS (₹): 16.44
Operating Margin %: 16.08%
Net Margin %: 12.29%
ROE %: 28.17%
ROCE %: 30.16%
: 18.47%
Debtor Days: 63
Inventory Days: 56
Payable Days: 67
: 51
Debt to Equity (x): 0.08x
Interest Coverage (x): 32.88x
: 3.70x
Revenue Growth %: 24.45%
Operating Profit Growth %: 101.03%
Net Profit Growth %: 146.63%
: 51.70%
P/E (x): 16.21x
P/B (x): 2.99x
Dividend Yield %: 0.41%
: 10.61x

Mar 2025

EPS (₹): 15.71
Book Value (₹): 92.57
Dividend per Share (₹): 1.00
Cash EPS (₹): 17.71
Operating Margin %: 15.84%
Net Margin %: 12.50%
ROE %: 18.44%
ROCE %: 23.65%
: 14.27%
Debtor Days: 82
Inventory Days: 46
Payable Days: 43
: 85
Debt to Equity (x): 0.01x
Interest Coverage (x): 127.65x
: 3.38x
Revenue Growth %: 7.77%
Operating Profit Growth %: 12.10%
Net Profit Growth %: 9.60%
: 9.60%
P/E (x): 11.49x
P/B (x): 1.95x
Dividend Yield %: 0.52%
: 7.29x

Mar 2026

EPS (₹): 18.28
Book Value (₹): 114.84
Dividend per Share (₹): 1.00
Cash EPS (₹): 20.22
Operating Margin %: 16.24%
Net Margin %: 12.57%
ROE %: 18.65%
ROCE %: 24.88%
: 15.01%
Debtor Days: 82
Inventory Days: 35
Payable Days: 32
: 84
Debt to Equity (x): 0.00x
Interest Coverage (x): 108.87x
: 2.98x
Revenue Growth %: 31.92%
Operating Profit Growth %: 31.34%
Net Profit Growth %: 32.65%
: 16.36%
P/E (x): 19.43x
P/B (x): 3.09x
Dividend Yield %: 0.28%
: 13.13x

Shareholding Pattern

Numbers in percentages

TRADES

	Mar 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	55.09	55.09	55.09	55.09	55.44	55.44	55.47	53.02
	0.03	0.02	0.01	0.01	0.00	0.29	0.58	0.91
	1.62	1.66	2.19	2.88	3.29	3.57	3.59	3.54
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	43.26	43.23	42.70	42.01	41.27	40.70	40.36	42.53

Mar 2024

: 55.09
: 0.03
: 1.62
Government: 0.00
: 43.26

Sep 2024

: 55.09
: 0.02
: 1.66
Government: 0.00
: 43.23

Mar 2025

: 55.09
: 0.01
: 2.19
Government: 0.00
: 42.70

Jun 2025

: 55.09
: 0.01
: 2.88
Government: 0.00
: 42.01

Sep 2025

: 55.44
: 0.00
: 3.29
Government: 0.00
: 41.27

Dec 2025

: 55.44
: 0.29
: 3.57
Government: 0.00
: 40.70

Mar 2026

: 55.47
: 0.58
: 3.59
Government: 0.00
: 40.36

Jun 2026

: 53.02
: 0.91
: 3.54
Government: 0.00
: 42.53

Documents

Announcements

Nothing filed yet.

Annual Reports

Credit Ratings

Nothing filed yet.

Concalls

May 2026
Transcript PPTREC
Aug 2025
TranscriptPPTREC
May 2025
Transcript PPTREC